PACB logo

PACB

Pacific Biosciences of California Inc.

$1.31
-$0.02(-1.50%)
28
Overall
--
Value
18
Tech
39
Quality
Market Cap
$396.49M
Volume
3.27M
52W Range
$0.85 - $2.72
Target Price
$2.05
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$92.8M$90.7M$93.5M$78.6M$90.9M$78.9M$130.5M$128.3M$200.5M$154.0M
Total Revenue
$37.5M$64.6M$93.5M$78.6M$90.9M$78.9M$130.5M$128.3M$200.5M$154.0M
COST OF GOODS SOLD
Cost of Revenue
$-30.7M$-34.5M$-58.8M$-53.5M$56.3M$46.3M$71.7M$3.7M$147.7M$116.7M
GROSS PROFIT
Gross Profit
$53.5M$44.2M$34.7M$25.1M$34.6M$32.6M$58.9M$49.0M$52.8M$37.3M
OPERATING EXPENSES
Operating Expenses
$-82.6M$-115.4M$-124.4M$-126.1M$135.1M$137.0M$269.3M$353.9M$387.2M$511.6M
Research & Development
$60.4M$67.6M$65.3M$62.6M$59.6M$64.2M$112.9M$193.0M$187.2M$134.9M
Research Expense
$60.4M$67.6M$65.3M$62.6M$59.6M$64.2M$112.9M$193.0M$187.2M$134.9M
Selling, General & Administrative
$45.2M$47.8M$59.1M$63.5M$75.5M$72.8M$124.1M$160.9M$171.8M$175.0M
Selling & Marketing Expenses
$45.2M$47.8M$59.1M$63.5M--------$2.0M--
General & Administrative Expenses
$-1.1M$-200.0K$-6.3M$-6.2M$75.5M$72.8M$124.1M$160.9M$169.8M$175.0M
Salaries & Wages
$-13.8M$-19.6M$-20.4M$-23.2M$16.4M$300.0K$900.0K$78.6M$600.0K$9.4M
Depreciation & Amortization
$-3.7M$-3.9M$-8.4M$-7.2M$7.3M$6.4M$7.2M$9.5M$11.5M$13.8M
Depreciation & Amortization
$-3.7M$-3.9M$-8.4M$-7.2M$7.3M$6.4M$7.2M$9.5M$6.2M$13.8M
Amortization
------------$410.5M$900.0K$470.6M$417.0M
Other Operating Expenses
$-23.0M$-115.4M$-124.4M$-126.1M$-1.5M$-1.2M$-2.2M$-2.1M$-2.1M$-3.1M
OPERATING INCOME
Operating income
$-29.1M$-71.2M$-183.3M$-179.6M$-100.5M$-104.4M$-210.4M$-307.2M$-334.5M$-474.3M
EBITDA
$-24.1M$-66.1M$-79.6M$-91.9M$-70.3M$39.0M$-250.8M$-281.5M$-291.6M$-256.2M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$2.9M$3.2M$2.9M$2.4M$2.6M$267.0K$12.5M$15.4M$14.3M--
Net Non-Operating Interest Income/Expense
$-2.9M$-3.2M$-2.9M$-2.4M$-2.6M$-267.0K$-12.5M$-15.4M$-14.3M--
Gain on Sale of Securities
$-344.0K$-244.0K----------$9.2M$32.8M$24.9M
Other Income/Expense
$-364.0K$-103.0K$-94.0M$-79.5M$-19.0M$-36.1M$53.4M$5.3M$-15.6M$-179.0M
Other Special Charges
$364.0K$103.0K$94.0M$79.5M$19.0M$36.1M$-51.9M$7.6M$30.7M$178.2M
SPECIAL ITEMS
Restructring And Mn A Income
------------------$12.8M
Special Income Charges
------------------$-184.5M
Impairment of Capital Assets
------------------$184.5M
PRE-TAX INCOME
EBIT
$-28.8M$-71.1M$-89.3M$-100.1M$-81.5M$29.7M$-262.3M$-298.8M$-318.2M$-309.5M
Pre-Tax Income
$-31.7M$-74.4M$-92.2M$-102.6M$-84.1M$29.4M$-274.9M$-314.2M$-318.2M$-309.5M
INCOME TAX
Tax Provision
----$-113.0M------$-93.6M--$-11.4M$316.0K
NET INCOME
Net Income
$-31.7M$-74.4M$-92.2M$-102.6M$-84.1M$29.4M$-181.2M$-314.2M$-306.7M$-309.9M
Net Income (Continuing Operations)
$-31.7M$-74.4M$-92.2M$-102.6M$-84.1M$29.4M$-181.2M$-314.2M$-306.7M$-309.9M
Net Income (Discontinued Operations)
$-31.7M$-74.4M$-92.2M$-102.6M$-84.1M$29.4M$-181.2M$-314.2M$-306.7M$-309.9M
Net Income (Common Stockholders)
$-31.7M$-74.4M$-92.2M$-102.6M$-84.1M$-68.6M$-181.2M$-314.2M$-306.7M$-309.9M
Normalized Income
------------------$-110.0M
TOTALS
Total Expenses
$-113.3M$-149.9M$-183.3M$-179.6M$191.4M$183.3M$340.9M$357.6M$535.0M$628.3M
SHARE & EPS DATA
Average Shares Outstanding
$75.6M$89.1M$105.7M$135.1M$152.5M$165.2M$204.1M$224.6M$253.6M$274.5M
Average Shares Outstanding (Diluted)
$78.3M$89.6M$106.0M$134.9M--$175.0M$204.1M$224.6M$253.6M$288.4M
Shares Outstanding
$85.7M$92.7M$130.7M$151.0M$153.1M$193.1M$221.2M$247.1M$268.0M$297.9M
Basic EPS
--------$-0.55$0.18$-0.89$-1.4$-1.21$-1.13
Basic EPS (Continuing Operations)
$-0.02------$-0.55$0.18$-0.89$-1.4$-1.21$-1.13
Diluted EPS
$-0.42$-0.83$-0.87$-0.76$-0.55$0.17$-0.89$-1.4$-1.21$-1.59
Diluted EPS (Continuing Operations)
$-0.02--------$0.17$-0.89$-1.4$-1.21$-1.59
OTHER METRICS
Acquisition Expense
------------$31.1M--$9.0M--
Commission Expenses
----------------$2.0M--
Development Expense
----------------$2.0M--
Interest Expense Operating
------------$306.0K------
Net Income From Other Gains Losses
----------$98.0M--------
Other Gand A
$-1.1M$-200.0K$-6.3M$-6.2M$75.5M$72.8M$124.1M$160.9M$169.8M$175.0M
Other Write Off
------------$306.0K------
Rent And Landing Fees
$-1.1M$-200.0K$-6.3M$-6.2M$-7.0M$-7.2M$-8.2M$-11.2M$-12.1M$-14.2M
Selling Expense
$45.2M$47.8M$59.1M$63.5M------------
Restruct
------------------$12.8M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2PACB$1.31-1.5%3.27M
3
4
5
6

Get Pacific Biosciences of California Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.